UA61054U - method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type - Google Patents

method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Info

Publication number
UA61054U
UA61054U UAU201014208U UAU201014208U UA61054U UA 61054 U UA61054 U UA 61054U UA U201014208 U UAU201014208 U UA U201014208U UA U201014208 U UAU201014208 U UA U201014208U UA 61054 U UA61054 U UA 61054U
Authority
UA
Ukraine
Prior art keywords
treatment
patients
hypertrophic
hypertension
evaluating
Prior art date
Application number
UAU201014208U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Николай Васильевич Ришко
Наталья Николаевна Демко
Ярослав Михайлович Бычка
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201014208U priority Critical patent/UA61054U/en
Publication of UA61054U publication Critical patent/UA61054U/en

Links

Landscapes

  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for evaluating the effectiveness of treatment with moexipril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type comprises the comparison of patients before and after treatment. Before the treatment with moexipril, to a patient at rest thevDoppler echocardiography is performed and the transmitral blood flow is determined by measuring the rate of early diastolic filling. After treatment with moexipril the similar study is performed. If the rate of early diastolic left ventricular filling increased by 10.5% or more compared with the rate before treatment, the hemodynamic and antianginal effect results are evaluated as positive.
UAU201014208U 2010-11-29 2010-11-29 method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type UA61054U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201014208U UA61054U (en) 2010-11-29 2010-11-29 method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201014208U UA61054U (en) 2010-11-29 2010-11-29 method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Publications (1)

Publication Number Publication Date
UA61054U true UA61054U (en) 2011-07-11

Family

ID=50835313

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201014208U UA61054U (en) 2010-11-29 2010-11-29 method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type

Country Status (1)

Country Link
UA (1) UA61054U (en)

Similar Documents

Publication Publication Date Title
UA61054U (en) method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA59603U (en) method for evaluating the effectiveness of treatment with benidipin of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA59604U (en) method for evaluating the effectiveness of treatment with ISRADIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA59605U (en) method for evaluating the effectiveness of treatment with MANIDIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61052U (en) method for evaluating the effectiveness of treatment with quinapril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA62007U (en) method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA95183C2 (en) Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61056U (en) method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA95184C2 (en) Method for assesment of effectiveness of treatment WITH VERAPAMIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61981U (en) method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA78607U (en) method for evaluating the effectiveness of treatment with candesartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of the left ventricular diastolic function by "hypertrophic" type
UA78612U (en) method for evaluating the effectiveness of treatment with losartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of left ventricular diastolic function by "hypertrophic" type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA54819U (en) Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA55363U (en) Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA59416U (en) Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA55362U (en) Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA56814U (en) Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA71709U (en) Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA72092U (en) Method for assessing efficacy of rozuvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA55225U (en) method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type